110 Startups
  • Sector
  • Participated in
  • Year of participation

Chiron

  • 2022
  • Enabling Technology
  • Venture Challenge
An organ-on-chip company with patent-protected technology for the mechanical stimulation of human cells, leveraged to develop joint models to study rheumatoid and osteoarthritis, animal free

ClearDetections

  • Diagnostics
  • Venture Challenge
ClearDetections offers agricultural (inspection) laboratories a turn-key solution that could completely replace the current routine nematode detection through microscopic examination, enabling large-scale, sensitive and accurate monitoring of soil quality.

Core Life Analytics

  • 2014
  • Enabling Technology
  • Venture Challenge
To empower scientists in the analysis of their own data sets, and open data; by giving them access to powerful, intuitive, web-based data analytics tools.

Cyclomics

  • 2017
  • Diagnostics
  • Venture Challenge
Detecting cancer recurrence before it’s too late

D4 Diagnostics

  • 2022
  • Diagnostics
  • Venture Challenge
D4 Diagnostics has developed D4BST to quantify the number of immune cells in tumors prior to treatment. D4BST is an assay for accurate, fast and reliable quantification of B-, Switched B- and T cells in traces of DNA from tumors or its surrounding environment.

DEPREDICT

  • 2023
  • Diagnostics
  • Venture Challenge
DEPREDICT uses cutting-edge machine learning and neuroimaging MRI to address the urgent need for decision support in treating depression, a global health crisis impacting over 40 million Europeans annually.

Digest Inn

  • 2016
  • Enabling Technology
  • Venture Challenge
Assisting people to make diet-related lifestyle changes through gaming

EdgeLeap

  • 2013
  • Enabling Technology
  • Venture Challenge
EdgeLeap is an information technology company pushing AI to its limits to surface business relevant insights from continuous stream of world’s information, helping their clients can make intelligent strategic decisions every day.

Encare Biotech

  • 2010
  • 2011
  • Other
  • Therapeutics
  • Venture Challenge
Firbornectin-EDA Monoclonal antibody for the prevention of chronic heart failure

Encytos

  • 2021
  • Enabling Technology
  • Venture Challenge
Encytos has developed a micro(nano)structured (topographic) inorganic substrate for spheroid and organoid cell growth.